期刊文献+

连云港地区成人尿足细胞标志蛋白podocalyxin生物参考区间的建立 被引量:3

Establishment of biological reference interval for urinary podocalyxin of adults in Lianyungang
原文传递
导出
摘要 目的初步建立连云港地区20~79岁健康成人尿podocalyxin (PCX)的生物参考区间。方法随机选取2017年1月至12月于连云港市第二人民医院体检中心体检的健康体检人员600例,年龄20~79岁,按要求留取血液和尿液标本,并测定血清指标和尿PCX水平,参照CLSI C28-A2和WS/T 402-2012《临床实验室检验项目参考区间的制定》中的方法,应用Z检验统计分析并建立尿PCX的生物参考区间。结果Z检验显示尿PCX的水平存在显著的性别差异(P〈0.05),但年龄分布上未见明显差异,需依据性别的不同建立相应的生物参考区间;尿PCX呈非正态分布,故应用第95百分位数(P95)建立参考区间,尿PCX的生物参考区间为男性0~5.99 ng/ml、女性0~6.41 ng/ml。结论尿PCX生物参考区间的建立,能够为临床肾脏疾病的早期筛查提供重要的指导意义。 Objective To primarily establish biological reference interval for urinary podocalyxin (PCX) in healthy adults aged 20 to 79 years in city of Lianyungang. Methods A total of 600 subjects, aging 20 to 79 years old, who experienced physical examination in Health Examination Center of the Sec- ond People's Hospital of Lianyungang from January to December of 2017 were selected randomly. And blood and urine samples were left as required. The levels of serum index and urinary PCX were detected. According to recommended method in CLSI C28-A2 and WS/T 402-2012 "Clinicallaboratory test project reference interval formulation", Z test was used to analyze and establish the biologic reference interval of urinary PCX. Results Z test showed the concentration of urinary PCX had significant gender difference (P 〈0. 05), but PCX did not vary with age. So the biologic reference interval of urinary PCX should be based on the difference of gender. Urinary PCX was with abnormal distribution, so the ninety-fifth percen- tile (P95) was used to establish biologic reference interval. The biologic reference interval of urinary PCX in male was 0 to 5. 99 ng/ml and was 0 to 6. 41 ng/ml in female, respectively. Conclusions Establishment of the biologic reference interval of urinary PCX may renal diseases in clinical. provide important guidance for the early screening of
作者 刘倩 杨伏猛 徐同道 梁伟 付梅 王西珍 卞光荣 Liu Qian;Yang Fumeng;Xu Tongdao;Liang Wei;Fu Mei;Wang Xizhen;Bian Guangrong(Department of Laboratory,the Second People's Hospital of Lianyungang,Lianyungang 222006,Chin)
出处 《中国实用医刊》 2018年第13期36-39,共4页 Chinese Journal of Practical Medicine
基金 连云港市卫生科研项目(201721)
关键词 足细胞标志蛋白 生物参考区间 肾脏疾病 Podocalyxin Biological reference interval Renal disease
  • 相关文献

参考文献3

二级参考文献30

  • 1Fioretto P, Bruseghin M, Berto I, et al. Renal protection in diabetes: role of glycemic control [ J ]. J Am Soc Nephrol, 2006, 17 (g Suppl 2) : S86-S89.
  • 2Kanwar YS, Wada J, Sun'L, et al. Diabetic nephropathy: mechanisms of renal disease progression[ J]. Exp Biol Med ( May wood), 2008,233 ( 1 ) :4 -11.
  • 3Doi T, Mima A, Matsubara T, et al. The current clinical problems for early phase of diabetic nepbropathy and approach for pathogenesis of diabetic nephropathy[ J]. Diabetes Res Clin Pract, 2008,82 ( Suppl 1 ) : S21-S24.
  • 4Miyauchi M, Toyoda M, Kobayashi K, et al. Hypertrophy and loss of podocytes in diabetic nephropathy [ J ]. Intern Med ,2009,48 ( 18 ) : 1615-1620.
  • 5Horn PS, Pesce AJ. Reference intervals: an update[ J]. Clin Chim Acta, 2003, 334(1-2) :5-23.
  • 6ISO 15189. Medical laboratories - Requirements for quality and competence-third edition [ S]. Geneva, Smitzerland : ISO ,2012.
  • 7中华人民共和国卫生部.WS/T404.1-2012.临床常用生化检验项目参考区间,第1部分:血清丙氨酸氨基转移酶、天门冬氨酸氨基转移酶、碱性磷酸酶和y-谷氨酰基转移酶[S].北京:中国标准出版社,2013.
  • 8中华人民共和国卫生部.WS/T404.2-2012.临床常用生化检验项目参考区间,第2部分:血清总蛋白、白蛋白[S].北京:中国标准出版社,2013.
  • 9中华人民共和国卫生部.WS/T404.3-2012.临床常用生化检验项目参考区间,第3部分:血清钾、钠、氯[S].北京:中国标准出版社,2013.
  • 10中华人民共和国卫生部.WS/T405-2012.血细胞分析参考区间[S].北京:中国标准出版社,2013.

共引文献41

同被引文献14

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部